Barclays’s BODY CENTRAL CORP COM STK BODY Stock Holding History

Barclays’s Portfolio BODY Stock Details BODY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-39,198	Closed	–	–	8082
2014 Q2	$0	Buy	39,198 +19,721	+101%	+$18.4K	﹤0.01%	8040
2014 Q1	$20K	Buy	19,477 +19,109	+5,193%	+$58K	﹤0.01%	6624
2013 Q4	$1K	Buy	368 +103	+39%	+$446	﹤0.01%	7496
2013 Q3	$2K	Buy	265 +53	+25%	+$469	﹤0.01%	7265
2013 Q2	$3K	Buy	+212	New	+$2.34K	﹤0.01%	7499

Other funds holding BODY

DIS

Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return

Barclays's BODY Position: Q3 2014 in Review

Barclays sold out of BODY CENTRAL CORP COM STK (BODY) in Q3 2014, closing a stake of 39,198 shares.

Barclays first reported a position in BODY in Q2 2013 and held it in 5 quarters. The position peaked at $20K in Q1 2014. 1 fund tracked by Wall St. Rank holds BODY as of Q3 2014.

Barclays reported no remaining BODY CENTRAL CORP COM STK position as of Q3 2014 after selling out during the quarter.
Barclays sold 39,198 BODY CENTRAL CORP COM STK shares in Q3 2014.
Barclays first reported a position in BODY CENTRAL CORP COM STK in Q2 2013 and held it in 5 quarters.
Barclays's BODY CENTRAL CORP COM STK position peaked at $20K in Q1 2014.
1 fund tracked by Wall St. Rank held BODY CENTRAL CORP COM STK as of Q3 2014.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.